Hyperthermia Therapy Practice School - 2025

Monday, November 17, 2025, 7:15 AM - Tuesday, November 18, 2025, 5:00 PM, BioPark Life Conference Center, Baltimore, MD

Advances in the applications, technologies and methodologies of radiation oncology continue to evolve rapidly and the delivery of radiation therapy has become more complex, making it imperative that radiation oncology professionals remain current in the state-of-the-art techniques. Hyperthermia therapy at 40-44°C (also known as thermotherapy) is a specialized adjuvant cancer therapy that is only available in a few radiation oncology clinics throughout the U.S. Similarly, proton therapy is a less invasive form of radiation that is currently only available in certain regions of the country. Hyperthermia therapy is a non-invasive procedure that has been used with traditional photon radiation and chemotherapy. The University of Maryland Division of Translational Radiation Sciences (DTRS) is now documenting the effectiveness of thermotherapy when applied with proton therapy, an effort that has no parallel in the U.S.

At the conclusion of this activity, participants will be able to:

1. Recall all the components required to establish a hyperthermia therapy program.

2. Distinguish the different biology of tumors and healthy tissues during elevated temperatures.

3. Decide proper patient eligibility for hyperthermia treatments and the most adequate modality: interstitial, superficial or deep hyperthermia therapy.

4. Define the radio- and chemosensitization effects induced by hyperthermia.

5. Describe the physics of radio waves and microwaves as well as the need for water bolus.

6. Explain how to position the different hyperthermia applicators and define the need for multiple treatment sites.

7. Perform treatment delivery of interstitial, superficial and deep hyperthermia therapy.

8. Analyze and report hyperthermia therapy treatment data.

9. Implement the clinical workflow, documentation and reimbursement of hyperthermia treatments.

10. Understand the reimbursement strategy for hyperthermia treatments.

Accreditation: The University of Maryland School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Credits: The University of Maryland School of Medicine designates this Live activity for a maximum of 14.00 AMA PRA Category 1 Credits ^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (14.00 hours), Non-Physician Attendance (14.00 hours)

Mitigation of Relevant Financial Relationships

University of Maryland School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No faculty are available for this activity at this time.